financetom
Business
financetom
/
Business
/
Netflix Stock Is Down 8%: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Netflix Stock Is Down 8%: What's Going On?
Mar 6, 2025 12:55 PM

Netflix Inc ( NFLX ) shares faced downward pressure on Thursday, falling some 8.69% to $904.66, amid escalating trade tensions and the impact of new tariffs on U.S. imports from Canada, Mexico and China.

What To Know: The tariffs, which took effect this week, have sparked retaliatory measures from trading partners, raising concerns over the global supply chain and the potential for higher operational costs for companies like Netflix ( NFLX ).

As a global streaming giant with extensive international operations, Netflix ( NFLX ) could see its costs rise, particularly in content acquisition and infrastructure expansion in affected markets.

Read Also: Retailers Warn Of Price Increases Due To Trump Tariffs As Consumer Health Concerns Persist

The broader market, including major indices, remained in the red, as investors reacted to the uncertain trade landscape. While a slight rebound occurred after comments from Commerce Secretary Howard Lutnick, who suggested potential exemptions for carmakers and progress on Mexico and Canada avoiding tariffs, the continued uncertainty has left many investors cautious.

What Else: Consumers could also feel the effects, as any increased operational costs for Netflix ( NFLX ) may be passed on in the form of higher subscription fees.

With economic pressures rising globally due to tariffs, consumers may be less willing to absorb price hikes, potentially impacting subscriber growth and retention, especially in price-sensitive markets. This could further exacerbate challenges for Netflix ( NFLX ) as it tries to balance profitability with subscriber demand.

Read Also: Mortgage Rates Drop Ahead Of Spring Homebuying Season: Will Consumers Take The Plunge?

How To Buy NFLX Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Netflix’s case, it is in the Communication Services sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

According to data from Benzinga Pro, NFLX has a 52-week high of $1,064.50 and a 52-week low of $542.01.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mirum Pharmaceuticals Q3 revenue rises on LIVMARLI sales growth
Mirum Pharmaceuticals Q3 revenue rises on LIVMARLI sales growth
Nov 4, 2025
Overview * Mirum Pharmaceuticals Q3 2025 revenue rises 47% yr/yr to $133 mln * Net income for Q3 2025 at $2.9 mln, a turnaround from loss last year * Mirum updates 2025 revenue guidance to $500-$510 mln Outlook * Mirum updates 2025 revenue guidance to $500-$510 mln * Company expects VISTAS study topline data in Q2 2026 * Mirum anticipates...
Soleno Therapeutics posts Q3 profit on strong VYKAT XR sales 
Soleno Therapeutics posts Q3 profit on strong VYKAT XR sales 
Nov 4, 2025
Overview * Soleno Q3 net income at $26 mln, achieving profitability with VYKAT XR sales * VYKAT XR sales reach $66 mln in Q3, more than doubling from previous quarter * Company raised $230 mln through stock offering, strengthening financial position Outlook * Soleno expects selling, general and administrative expenses to rise post-VYKAT XR commercialization Result Drivers * VYKAT XR...
Tech firm Mercury Systems Q1 profit beats expectations on strong demand 
Tech firm Mercury Systems Q1 profit beats expectations on strong demand 
Nov 4, 2025
Overview * Mercury Systems ( MRCY ) fiscal Q1 rev grows 10.2% yr/yr, beating analyst expectations * Adjusted EPS for fiscal Q1 beats consensus, improving significantly year-over-year * Company announced $200 mln share repurchase program, reflecting confidence in future prospects Outlook * Mercury Systems ( MRCY ) did not provide specific future revenue or EPS guidance in the statement Result...
Day One Biopharmaceuticals Q3 revenue beats estimates on OJEMDA strength
Day One Biopharmaceuticals Q3 revenue beats estimates on OJEMDA strength
Nov 4, 2025
Overview * Day One Q3 revenue of $39.8 mln beats analyst expectations * OJEMDA net product revenue rises 15% from Q2, driven by higher patient demand * Company raises full-year 2025 OJEMDA revenue guidance to $145-$150 mln Outlook * Company raises OJEMDA full-year 2025 revenue guidance to $145-$150 mln Result Drivers * INCREASED DEMAND - OJEMDA net product revenue rose...
Copyright 2023-2026 - www.financetom.com All Rights Reserved